Novel compounds, that exhibit insulin-like effects, improve insulin sensitivity, enhance the efficacy of already existing antidiabetic agents and have very few side effects, are greatly desired as they will broaden the spectrum of treatment options for insulin resistance and T2DM. Here, INS is linked to type 2 diabetes mellitus.